Sol-gel Technologies Ltd. balance sheet
At the end of fiscal 2025, Sol-gel Technologies Ltd. had total assets of $29.9m, total liabilities of $7.1m and shareholders' equity of $22.8m. It held $11.0m in cash against $0 of debt: net cash of $11.0m.
Balance sheet
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5 | 5 | 9 | 7 | 20 | 12 | 8 | 19 | 11 |
| Receivables | — | — | 4 | 2 | 13 | 0 | 0 | 4 | 2 |
| Total current assets | 11 | 66 | 56 | 53 | 57 | 43 | 41 | 31 | 27 |
| Total assets | 15 | 70 | 61 | 59 | 69 | 47 | 45 | 36 | 30 |
| Accounts payable | 1 | 3 | 2 | 1 | 1 | — | — | — | — |
| Total current liabilities | 67 | 5 | 7 | 6 | 12 | 3 | 5 | 5 | 6 |
| Short-term debt | 65 | — | — | — | — | — | — | — | — |
| Total debt | 65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 68 | 6 | 9 | 8 | 14 | 4 | 7 | 7 | 7 |
| Shareholders' equity | −53 | 64 | 52 | 51 | 56 | 42 | 39 | 29 | 23 |
| Net debt (negative = net cash) | 60 | −5 | −9 | −7 | −20 | −12 | −8 | −19 | −11 |
| Shares outstanding | — | — | — | — | — | — | — | 3m | 3m |
Compare with peers
- Zhengye Biotechnology Holding Ltd balance sheet
- Jaguar Health, Inc. balance sheet
- Verrica Pharmaceuticals Inc. balance sheet
- Scilex Holding Co balance sheet
- Sunshine Biopharma Inc. balance sheet
Head to head: SLGL vs ZYBTJAGX vs SLGLSLGL vs VRCA
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies